SCHEMBL8511465

SCHEMBL8511465

CC(C)NC(=O)c1ccc2c(c1)CCN2

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 2/20 0.54
KDM4E B2RXH2 1/20 0.54
ALDH1A1 P00352 2/20 0.47
CYP2C9 P11712 1/20 0.47
ALOX15 P16050 1/20 0.47
CYP2C19 P33261 1/20 0.47
DRD2 P14416 1/20 0.46
DRD4 P21917 1/20 0.46
PLAU P00749 1/20 0.44
PIR O00625 1/20 0.43
GSK3B P49841 1/20 0.43
HSF1 Q00613 1/20 0.43
SIRT2 Q8IXJ6 1/20 0.42
MLYCD O95822 1/20 0.42
GFER P55789 1/20 0.42
GAA P10253 2/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL45745 0.93 MAPT (0.64) MAPTKDM4EALDH1A1CYP2C9ALOX15
SCHEMBL18006523 0.84 ALDH1A1 (0.52) ALDH1A1CYP2C9CYP2C19GSK3BGAA
SCHEMBL18006529 0.84 ALDH1A1 (0.52) ALDH1A1CYP2C9CYP2C19GSK3BGAA
SCHEMBL30445913 0.80 MAPT (0.54) MAPTKDM4EALDH1A1CYP2C9ALOX15
SCHEMBL288320 0.80 MAPT (0.54) MAPTKDM4EALDH1A1CYP2C9ALOX15
SCHEMBL11807591 0.80 KDM4E (0.54) MAPTKDM4EALDH1A1CYP2C9ALOX15
SCHEMBL18280582 0.79 KDM4E (0.58) MAPTKDM4EALDH1A1CYP2C9GSK3B
SCHEMBL18280584 0.79 KDM4E (0.58) MAPTKDM4EALDH1A1CYP2C9GSK3B
Hydrochloric Acid SCHEMBL699425 0.79 MAPT (0.53) MAPTKDM4EALDH1A1CYP2C9ALOX15
SCHEMBL18006525 0.79 PPARG (0.49) MAPTKDM4EALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9000175-B2 Bicyclic GPR119 modulators LUPIN LIMITED (IN) 2015-04-07 US disclosed
EP-2643311-A1 BICYCLIC GPR119 MODULATORS Lupin Limited (IN) 2013-10-02 EP disclosed
US-20130245000-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2013-09-19 US disclosed
WO-2012069917-A1 BICYCLIC GPR119 MODULATORS LUPIN LIMITED (IN) 2012-05-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130245000-A1 BICYCLIC GPR119 MODULATORS GPR119, GPR180, GPBAR1 MAPT 4305/4885KDM4E 4040/4885ALDH1A1 1436/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.